Comparison of Abbreviated MRI and Full Diagnostic Protocol MRI for Surgical Planning in Patients with Newly Diagnosed Breast Cancer

比较简化版MRI和完整诊断方案MRI在初诊乳腺癌患者手术计划中的应用

阅读:2

Abstract

Objective: This study aimed to compare the concordance of abbreviated MRI (AB-MRI) and full diagnostic protocol MRI (FDP-MRI) with pathology in assessing tumor extent for surgical planning in patients with newly diagnosed breast cancer. Additionally, we evaluated the performance of AB-MRI and FDP-MRI in detecting additional malignant lesions in the ipsilateral breast. Materials and Methods: A total of 319 patients with 330 index breast cancers were enrolled in the study. Two radiologists independently assessed tumor extent on AB-MRI and FDP-MRI and compared their measurements with the pathological tumor extent. For both MRI protocols, concordance rates and agreement of tumor extent with pathology were analyzed according to histopathologic and molecular subtypes using the chi-square test and ICC. Additional malignant lesions detection rates in the ipsilateral breast were compared between the two MRI protocols. Results: The mean total pathologic tumor extent, including the in situ component and adjacent malignant lesions, was 2.2 cm (standard deviation [SD]: 1.3 cm; range: 0.7-8.5 cm). The concordance rate of tumor extent with pathology between the two MRI protocols (AB- and FDP-MRI) showed no significant difference (reader 1, p = 0.68; reader 2, p = 0.74). The agreement of tumor extent with pathology was not significantly different between the two MRI protocols (AB-MRI and FDP-MRI: K = 0.70, 0.75, p = 0.17 in reader 1; K = 0.65, 0.71, p = 0.15 in reader 2). The detection rate of additional malignant lesions showed no significant difference between AB-MRI and FDP-MRI (p = 0.71 in reader 1, p = 0.89 in reader 2). Conclusions: AB-MRI is comparable to FDP-MRI for assessing tumor extent and detecting additional malignant lesions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。